Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01540773 · ClinicalTrials.gov registry record · NA
Single Low-Dose of Supplement Amino Acid
A NA study of Growth Hormone and Amino Acid, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01540773: Completed NA study of Growth Hormone and Amino Acid, sponsored by Pennington Biomedical Research Center.
NCT01540773 is a NA study of Growth Hormone and Amino Acid that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01540773, a NA study of Growth Hormone and Amino Acid, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.
Primary Outcome
Measure human growth hormone at times 0-120 minutes on two occasions about one week apart. On one occasion, the proprietary amino acid derivative blend will be given orally at time 0 in capsule form, and on the other occasion the capsules will contain no amino acids.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Amino acid supplement
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01540773 record still lists
NCT01540773 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Growth Hormone appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01540773 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01540773 about?
NCT01540773 is a clinical study titled "Single Low-Dose of Supplement Amino Acid". The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.
What is the current status of trial NCT01540773?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2011-10. Estimated completion is 2012-03.
What conditions does trial NCT01540773 study?
This clinical trial studies the following conditions: Growth Hormone, Amino Acid.
What interventions are being tested in trial NCT01540773?
The interventions under investigation include: Placebo (DRUG), Amino acid supplement (DRUG).
Who is sponsoring clinical trial NCT01540773?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01540773 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth Hormone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01540773's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia